10 Apr 2017
(MENAFN) Egypt should enhance its collaboration in pharmaceutical sector with India, which has great advantages in terms of offering affordable and reliable medication.
Accordingly, Egypt is a huge market in which India sees growing export potentials as well as possibilities of investments, while it aims that the market will offer India the base to increase to other parts of the region.
Additionally, India formulation is backed by globally acceptable certification and updated by increasing R&D facilities.
India’s exports of pharmaceuticals in 2015/16 reached USD16.86bn, while Indian pharmaceutical industry with several thousand producers, export the largest share of generics to the world.
MENAFN1004201700450000ID1095382304
MENAFN1004201700450000ID1095382304
05 Nov 2025
BBK partners with ARRAY to launch Innovation Center, hiring Bahraini software engineers to accelerate digital transformation
04 Nov 2025
On the sidelines of Gateway Gulf 2025, BBK signs landmark MoU with Binance for first-of-its-kind Crypto-as-a-service integration in the GCC
04 Nov 2025
On the sidelines of Gateway Gulf 2025, BBK partners with Panmure Liberum to enhance investment banking capabilities in the Kingdom of Bahrain and the GCC
30 Oct 2025
BBK discloses its financial results for the period ended 30th September 2025
17 Sep 2025
BBK and CrediMax launch exclusive offers for customers in collaboration with The Ritz-Carlton, Bahrain
31 Aug 2025
BBK announces an exceptional 6-month grace period financing campaign for Personal and Car Finance customers
13 Aug 2025
BBK’s BD 5,000,000 Al Hayrat scheme awards BD 680,000 to 390 Al Hayrat winners in August and September
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more